non fda approved semaglutide Tirzepatide vs. Semaglutide: What You Should Know FDA Approves Oral Semaglutide: First
Description
While they work through different mechanisms, the combined effect could potentially lead to hypoglycemia, characterized by dizziness, confusion, and shakiness

Short-term effects at 28 and 68 weeks were implemented using the trial-informed ratio method used in COM, a timepoint scaling factor used to preserve the empirically observed trajectory of treatment effects such as weight change between weeks 28 and 68
Because the medication slows down your digestion, your body needs time to adjust

Glucagon in the Treatment of Pagets Disease of Bone
Knudsen LB, et al